gimli

SUDEEPPHRM stock AI analysis

SUDEEPPHRM Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

SUDEEP PHARMA LIMITED is a small-cap stock in Chemicals. This Gimli page shows the latest available SUDEEPPHRM price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive SUDEEPPHRM stock page

Price

₹1,099.40

1W return

+7.53%

1M return

-8.37%

3M return

+26.72%

6M return

+55.38%

1Y return

n/a

Market cap

₹12,417.57 cr

70.31

13.83

ROE

+41.60%

ROCE

+46.26%

RSI

52.74

Turnover

₹19.12 cr

Why it can matter in screens

Momentum: SUDEEPPHRM is below 50DMA, above 200DMA; RSI is 52.74.
Returns: 1D -0.70%, 1W +7.53%, 1M -8.37%, 3M +26.72%, 1Y n/a.
Trend levels: 52W high ₹1,378.00, 52W low ₹721.10, off high -20.22%.
Liquidity: latest turnover is ₹19.12 cr; volume vs 20D is +0.57%.
Valuation/profitability: PE 70.31, PB 13.83, ROE +41.60%, ROCE +46.26%.
Growth: 3Y sales CAGR -4.00%, 3Y profit CAGR +19.95%.

Quick Answers

What is the latest SUDEEPPHRM stock price?

The latest stored price for SUDEEPPHRM is Rs 1,099.40 as of 2026-11-03.

Is SUDEEPPHRM above its 50DMA and 200DMA?

SUDEEPPHRM is below 50DMA, above 200DMA. The latest 50DMA is 1,134.73 and the latest 200DMA is 827.84.

What are SUDEEPPHRM PE, ROE and ROCE?

SUDEEPPHRM has PE 70.31, ROE +41.60%, and ROCE +46.26% in Gimli's latest available snapshot.

How has SUDEEPPHRM performed recently?

SUDEEPPHRM has returned -8.37% over 1 month, +26.72% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-06-30	115.48 cr	49.00 cr	33.83 cr	3.59
2026-03-31	188.76 cr	69.02 cr	48.54 cr	nan
2025-12-31	172.34 cr	66.81 cr	47.46 cr	4.29
2025-09-30	172.84 cr	65.63 cr	46.78 cr	4.05
2025-06-30	124.19 cr	48.53 cr	30.81 cr	2.73
2025-03-31	152.96 cr	61.35 cr	44.15 cr	nan
2024-12-31	115.54 cr	41.73 cr	28.71 cr	2.54

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	377.01 cr	158.27 cr	107.58 cr	9.65
2025-03-31	497.41 cr	198.09 cr	138.69 cr	12.28
2024-03-31	454.67 cr	186.90 cr	133.19 cr	11.79
2023-03-31	426.17 cr	97.30 cr	62.32 cr	5.52
2022-03-31	353.02 cr	76.22 cr	52.31 cr	371.20

Balance sheet

Period	Assets	Cash	Debt	Equity
2025-03-31	717.17 cr	36.81 cr	137.55 cr	493.09 cr
2024-03-31	513.87 cr	13.98 cr	78.08 cr	356.03 cr
2023-03-31	420.11 cr	10.30 cr	83.08 cr	223.28 cr

Cash flow

Period	OCF	FCF	Cash change
2025-03-31	48.73 cr	-15.51 cr	n/a
2024-03-31	65.69 cr	13.22 cr	n/a
2023-03-31	48.40 cr	1.24 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-06-30	+76.15%	+1.81%	+15.65%	+5.47%	+6.39%	+0.00%
2026-03-31	+76.15%	+1.55%	+18.11%	+6.19%	+4.18%	+0.00%
2025-12-31	+76.15%	+1.67%	+17.60%	+5.67%	+4.58%	+0.00%
2025-11-27	+76.15%	+1.54%	+14.76%	+3.44%	+7.54%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SOLARINDS	SOLAR INDUSTRIES (I) LTD	177,849.24 cr	89.308648	+35.93%	+38.79%
PIDILITIND	PIDILITE INDUSTRIES LTD	153,775.67 cr	57.934766	+25.27%	+3.45%
SRF	SRF LTD	71,985.16 cr	31.535509	+17.12%	-18.18%
COROMANDEL	COROMANDEL INTERNTL. LTD	53,402.96 cr	29.341155	+14.95%	-15.49%
LINDEINDIA	LINDE INDIA LIMITED	49,878.46 cr	91.292306	+13.51%	-2.90%
FLUOROCHEM	GUJARAT FLUOROCHEM LTD	49,035.94 cr	79.993379	+8.06%	+19.73%
FACT	FACT LTD	46,268.88 cr	-437.241385	-7.78%	-21.26%
NAVINFLUOR	NAVIN FLUORINE INT. LTD	43,740.05 cr	59.346361	+22.33%	+44.44%

Try these prompts

Analyze SUDEEP PHARMA with valuation, momentum and industry peers
Compare SUDEEPPHRM with other Chemicals stocks
Show small-cap stocks in Chemicals above 50DMA with positive 1M return
Find Chemicals stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-11-03. Not investment advice.